It always doesn't turn out as they wish. Pharmac
Post# of 145262
Pharmacyclics trading around $1 and struggling, was sold for $261/shr just in half a decade later.
And that was over 20% premium over Janssen's bid, if I recall.
I'm here as, I have seen what happened to Pharmacyclics. Well, It takes time and there is a bit of risk. No so much, at this price.
![](/images/icons/icon_smile.gif)
Happy Holidays Everyone!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)